Cargando…
The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG
Millions of people around the world suffer from amyloid-related disorders, including Alzheimer’s and Parkinson’s diseases. Despite significant and sustained efforts, there are still no disease-modifying drugs available for the majority of amyloid-related disorders, and the overall failure rate in cl...
Autores principales: | Sneideris, Tomas, Sakalauskas, Andrius, Sternke-Hoffmann, Rebecca, Peduzzo, Alessia, Ziaunys, Mantas, Buell, Alexander K., Smirnovas, Vytautas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995563/ https://www.ncbi.nlm.nih.gov/pubmed/31835741 http://dx.doi.org/10.3390/biom9120855 |
Ejemplares similares
-
Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
por: Ziaunys, Mantas, et al.
Publicado: (2021) -
Concentration-dependent polymorphism of insulin amyloid fibrils
por: Sakalauskas, Andrius, et al.
Publicado: (2019) -
Autoxidation Enhances Anti-Amyloid Potential of Flavone Derivatives
por: Sakalauskas, Andrius, et al.
Publicado: (2021) -
Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils
por: Sakalauskas, Andrius, et al.
Publicado: (2020) -
Exploring the potential of deep-blue autofluorescence for monitoring amyloid fibril formation and dissociation
por: Ziaunys, Mantas, et al.
Publicado: (2019)